Advertisement
Screener

DEXCOM, INC. (DXCM) Other Noncash Income (Expense)

3.4 / 5 stars · 72/106 Roast Me

DEXCOM, INC. Other Noncash Income (Expense)

DEXCOM, INC. (DXCM) reported Other Noncash Income (Expense) of $200.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.

Financial Statements › Cash Flow › Operating Activities

us-gaap:OtherNoncashIncomeExpense · last filed 2026-07-30

  • DEXCOM, INC. other noncash income (expense) for the quarter ending 2026-06-30 was $200.00K, a 75.00% decline year-over-year.
  • DEXCOM, INC. other noncash income (expense) for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
  • DEXCOM, INC. other noncash income (expense) for the quarter ending 2025-12-31 was $3.10M.
  • DEXCOM, INC. other noncash income (expense) for the quarter ending 2025-09-30 was $1.40M, a 96.61% decline year-over-year.
  • DEXCOM, INC. other noncash income (expense) for fiscal 2025 was $21.80M, a 55.24% decline from fiscal 2024.
  • DEXCOM, INC. other noncash income (expense) for fiscal 2024 was $48.70M, a 41.95% decline from fiscal 2023.
  • DEXCOM, INC. other noncash income (expense) for fiscal 2023 was $83.90M.
  • DEXCOM, INC. other noncash income (expense) for fiscal 2022 was -$34.50M.
Period endOther Noncash Income (Expense) 3 monthOther Noncash Income (Expense) 3 month as first filedOther Noncash Income (Expense) 6 monthOther Noncash Income (Expense) 6 month as first filedOther Noncash Income (Expense) 9 monthOther Noncash Income (Expense) 9 month as first filedOther Noncash Income (Expense) 12 monthOther Noncash Income (Expense) 12 month as first filed
2026-06-30$200.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
$200.00K
10-Q · filed 2026-07-30
$3.30M
derived: sum of 3 quarters · filed 2026-07-30
$4.70M
derived: sum of 4 quarters · filed 2026-07-30
2026-03-31$0.00
10-Q · filed 2026-04-30
$3.10M
derived: sum of 2 quarters · filed 2026-04-30
$4.50M
derived: sum of 3 quarters · filed 2026-04-30
$5.30M
derived: sum of 4 quarters · filed 2026-07-30
2025-12-31$3.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$4.50M
derived: sum of 2 quarters · filed 2026-02-12
$5.30M
derived: sum of 3 quarters · filed 2026-07-30
$21.80M
10-K · filed 2026-02-12
2025-09-30$1.40M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$2.20M
derived: sum of 2 quarters · filed 2026-07-30
$18.70M
10-Q · filed 2025-10-30
$2.70M
derived: sum of 4 quarters · filed 2026-07-30
2025-06-30$800.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30
$17.30M
10-Q · filed 2026-07-30
$12.70M
10-Q · filed 2025-07-30
$1.30M
derived: sum of 3 quarters · filed 2026-07-30
$42.60M
derived: sum of 4 quarters · filed 2026-07-30
2025-03-31$16.50M
10-Q · filed 2026-04-30
$12.30M
10-Q · filed 2025-05-01
$500.00K
derived: sum of 2 quarters · filed 2026-04-30
$41.80M
derived: sum of 3 quarters · filed 2026-04-30
$57.40M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31-$16.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$25.30M
derived: sum of 2 quarters · filed 2026-02-12
$40.90M
derived: sum of 3 quarters · filed 2026-02-12
$48.70M
10-K · filed 2026-02-12
$47.30M
10-K · filed 2025-02-18
2024-09-30$41.30M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30
$56.90M
derived: sum of 2 quarters · filed 2025-10-30
$64.70M
10-Q · filed 2025-10-30
$63.30M
10-Q · filed 2024-10-24
$100.30M
derived: sum of 4 quarters · filed 2026-02-12
2024-06-30$15.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30
$23.40M
10-Q · filed 2025-07-30
$59.00M
derived: sum of 3 quarters · filed 2026-02-12
$77.90M
derived: sum of 4 quarters · filed 2026-02-12
2024-03-31$7.80M
10-Q · filed 2025-05-01
$43.40M
derived: sum of 2 quarters · filed 2026-02-12
$62.30M
derived: sum of 3 quarters · filed 2026-02-12
$78.00M
derived: sum of 4 quarters · filed 2026-02-12
2023-12-31$35.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-12
$54.50M
derived: sum of 2 quarters · filed 2026-02-12
$70.20M
derived: sum of 3 quarters · filed 2026-02-12
$83.90M
10-K · filed 2026-02-12
2023-09-30$18.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-24
$34.60M
derived: sum of 2 quarters · filed 2024-10-24
$48.30M
10-Q · filed 2024-10-24
$47.30M
10-Q · filed 2023-10-26
$45.70M
derived: sum of 4 quarters · filed 2025-02-18
2023-06-30$15.70M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-25
$29.40M
10-Q · filed 2024-07-25
$26.80M
derived: sum of 3 quarters · filed 2025-02-18
$10.90M
derived: sum of 4 quarters · filed 2025-02-18
2023-03-31$13.70M
10-Q · filed 2024-04-25
$11.10M
derived: sum of 2 quarters · filed 2025-02-18
-$4.80M
derived: sum of 3 quarters · filed 2025-02-18
-$17.00M
derived: sum of 4 quarters · filed 2025-02-18
2022-12-31-$2.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-18
-$18.50M
derived: sum of 2 quarters · filed 2025-02-18
-$30.70M
derived: sum of 3 quarters · filed 2025-02-18
-$34.50M
10-K · filed 2025-02-18
-$34.70M
10-K · filed 2023-02-09
2022-09-30-$15.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-26
-$28.10M
derived: sum of 2 quarters · filed 2023-10-26
-$31.90M
10-Q · filed 2023-10-26
-$45.00M
derived: sum of 4 quarters · filed 2024-02-08
2022-06-30-$12.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27
-$16.00M
10-Q · filed 2023-07-27
-$29.10M
derived: sum of 3 quarters · filed 2024-02-08
-$43.60M
derived: sum of 4 quarters · filed 2024-02-08
2022-03-31-$3.80M
10-Q · filed 2023-04-27
-$16.90M
derived: sum of 2 quarters · filed 2024-02-08
-$31.40M
derived: sum of 3 quarters · filed 2024-02-08
-$39.40M
derived: sum of 4 quarters · filed 2024-02-08
2021-12-31-$13.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08
-$27.60M
derived: sum of 2 quarters · filed 2024-02-08
-$35.60M
derived: sum of 3 quarters · filed 2024-02-08
-$43.60M
10-K · filed 2024-02-08
2021-09-30-$14.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-27
-$22.50M
derived: sum of 2 quarters · filed 2022-10-27
-$30.50M
10-Q · filed 2022-10-27
-$38.70M
derived: sum of 4 quarters · filed 2023-02-09
2021-06-30-$8.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-28
-$16.00M
10-Q · filed 2022-07-28
-$24.20M
derived: sum of 3 quarters · filed 2023-02-09
-$26.20M
derived: sum of 4 quarters · filed 2023-02-09
2021-03-31-$8.00M
10-Q · filed 2022-04-28
-$16.20M
derived: sum of 2 quarters · filed 2023-02-09
-$18.20M
derived: sum of 3 quarters · filed 2023-02-09
-$21.60M
derived: sum of 4 quarters · filed 2023-02-09
2020-12-31-$8.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-09
-$10.20M
derived: sum of 2 quarters · filed 2023-02-09
-$13.60M
derived: sum of 3 quarters · filed 2023-02-09
-$13.70M
10-K · filed 2023-02-09
2020-09-30-$2.00M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-28
-$5.40M
derived: sum of 2 quarters · filed 2021-10-28
-$5.50M
10-Q · filed 2021-10-28
-$4.10M
10-Q · filed 2020-10-27
-$6.80M
derived: sum of 4 quarters · filed 2022-02-14
2020-06-30-$3.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29
-$3.50M
10-Q · filed 2021-07-29
-$4.80M
derived: sum of 3 quarters · filed 2022-02-14
-$7.30M
derived: sum of 4 quarters · filed 2022-02-14
2020-03-31-$100.00K
10-Q · filed 2021-04-29
-$1.40M
derived: sum of 2 quarters · filed 2022-02-14
-$3.90M
derived: sum of 3 quarters · filed 2022-02-14
-$1.70M
derived: sum of 4 quarters · filed 2022-02-14
2019-12-31-$1.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-14
-$3.80M
derived: sum of 2 quarters · filed 2022-02-14
-$1.60M
derived: sum of 3 quarters · filed 2022-02-14
-$1.90M
10-K · filed 2022-02-14
-$2.10M
10-K · filed 2020-02-13
2019-09-30-$2.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-27
-$300.00K
derived: sum of 2 quarters · filed 2020-10-27
-$600.00K
10-Q · filed 2020-10-27
-$2.40M
derived: sum of 4 quarters · filed 2021-02-11
2019-06-30$2.20M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28
$1.90M
10-Q · filed 2020-07-28
$100.00K
derived: sum of 3 quarters · filed 2021-02-11
-$300.00K
derived: sum of 4 quarters · filed 2021-02-11
2019-03-31-$300.00K
10-Q · filed 2020-04-28
-$2.10M
derived: sum of 2 quarters · filed 2021-02-11
-$2.50M
derived: sum of 3 quarters · filed 2021-02-11
-$8.10M
derived: sum of 4 quarters · filed 2021-02-11
2018-12-31-$1.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-11
-$2.20M
derived: sum of 2 quarters · filed 2021-02-11
-$7.80M
derived: sum of 3 quarters · filed 2021-02-11
-$6.90M
10-K · filed 2021-02-11
-$4.70M
10-K · filed 2019-02-21
2018-09-30-$400.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06
-$6.00M
derived: sum of 2 quarters · filed 2019-11-06
-$5.10M
10-Q · filed 2019-11-06
-$5.00M
10-Q · filed 2018-11-06
-$9.80M
derived: sum of 4 quarters · filed 2020-02-13
2018-06-30-$5.60M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31
-$4.70M
10-Q · filed 2019-07-31
-$9.40M
derived: sum of 3 quarters · filed 2020-02-13
-$6.50M
derived: sum of 4 quarters · filed 2020-02-13
2018-03-31$900.00K
10-Q · filed 2019-05-01
-$3.80M
derived: sum of 2 quarters · filed 2020-02-13
-$900.00K
derived: sum of 3 quarters · filed 2020-02-13
-$6.70M
derived: sum of 4 quarters · filed 2020-02-13
2017-12-31-$4.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13
-$1.80M
derived: sum of 2 quarters · filed 2020-02-13
-$7.60M
derived: sum of 3 quarters · filed 2020-02-13
-$7.90M
10-K · filed 2020-02-13
2017-09-30$2.90M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06
-$2.90M
derived: sum of 2 quarters · filed 2018-11-06
-$3.20M
10-Q · filed 2018-11-06
2017-06-30-$5.80M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01
-$6.10M
10-Q · filed 2018-08-01
2017-03-31-$300.00K
10-Q · filed 2018-05-02
2016-12-31-$2.20M
10-K · filed 2019-02-21
2012-06-30$60.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06
-$1.00K
10-Q · filed 2012-08-06
2012-03-31-$61.00K
10-Q · filed 2012-05-02
2011-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-06
$0.00
10-Q · filed 2012-08-06
2011-03-31$0.00
10-Q · filed 2012-05-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
WEST PHARMACEUTICAL SERVICES INC (WST)United States$26.288B43.14
BECTON DICKINSON & CO (BDX)United States$48.834B43.79
Solventum Corp (SOLV)United States$15.085B9.16
Penumbra Inc (PEN)United States$12.596B77.33
BAXTER INTERNATIONAL INC (BAX)United States$12.139B-10.35
GLOBUS MEDICAL INC (GMED)United States$9.977B20.03
INSULET CORP (PODD)United States$9.420B28.12
GLAUKOS Corp (GKOS)United States$9.135B-43.73
MiniMed Group, Inc. (MMED)United States$5.748B-16.85
MERIT MEDICAL SYSTEMS INC (MMSI)United States$5.212B28.44